{"id":"F2021L00360","name":"Seafarers Rehabilitation and Compensation (Specified Diseases and Employment) Instrument 2021","slug":"seafarers-rehabilitation-and-compensation-specified-diseases-and-employment-instrument-2021","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":101575,"registerId":"commonwealth-F2021L00360-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Name","content":"#### 1 Name\n\n This instrument is the Seafarers Rehabilitation and Compensation (Specified Diseases and Employment) Instrument 2021.","sortOrder":0},{"sectionNumber":"2","sectionType":"section","heading":"Commencement","content":"#### 2 Commencement\n\n This instrument commences on the day after it is registered on the Federal Register of Legislation.","sortOrder":1},{"sectionNumber":"3","sectionType":"section","heading":"Authority","content":"#### 3 Authority\n\n This instrument is made under paragraph 10(1)(b) of the Seafarers Rehabilitation and Compensation Act 1992.","sortOrder":2},{"sectionNumber":"4","sectionType":"section","heading":"Definitions","content":"#### 4 Definitions\n\n In this instrument:\n\n> Act means the Seafarers Rehabilitation and Compensation Act 1992.\n\n> disease has its ordinary meaning.\n\n> substance means any natural or artificial substance, whether in the form of a solid, liquid, gas or vapour.","sortOrder":3},{"sectionNumber":"5","sectionType":"section","heading":"Application","content":"#### 5 Application\n\n This instrument applies in relation to a disease that an employee suffers on or after the day this instrument commences.","sortOrder":4},{"sectionNumber":"6","sectionType":"section","heading":"Schedules","content":"#### 6 Schedules\n\n Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.","sortOrder":5},{"sectionNumber":"7","sectionType":"section","heading":"Specification","content":"#### 7 Specification\n\n For the purposes of paragraph 10(1)(b) of the Act, a disease of a kind specified in column 1 of an item of the table in Schedule 1 is a disease related to employment of a kind specified in column 2 of that item.","sortOrder":6},{"sectionNumber":"8","sectionType":"section","heading":"Repeal","content":"#### 8 Repeal\n\n This instrument is repealed the day after the end of the period of 5 years beginning on the day this instrument commences.\n\n \nSchedule 1—Specification\n\n```html\n

Column 1

Column 2

Item

Disease

Employment

Infectious diseases

1

Anthrax

Employment involving work with:

  1. animals; or
  2. animal carcasses; or
  3. animal parts.

2

Brucellosis

Employment involving work with:

  1. animals; or
  2. animal carcasses; or
  3. animal parts; or
  4. animal waste.

3

Hepatitis A

Employment involving work with human waste.

4

Hepatitis B or Hepatitis C

Employment involving work with human body fluids.

5

Human Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS)

Employment involving work with:

  1. needles in a healthcare services setting; or
  2. sharps in a healthcare services setting.

6

Leptospirosis

Employment involving work with:

  1. animals; or
  2. animal carcasses; or
  3. animal parts; or
  4. animal waste.

7

Orf

Employment involving work with:

  1. goats; or
  2. goat carcasses; or
  3. sheep; or
  4. sheep carcasses.

8

Q-fever

Employment involving work with:

  1. animals; or
  2. animal carcasses; or
  3. animal parts.

9

Tuberculosis

Employment involving work with:

  1. animals:

(i) in a farming setting; or

(ii) in a veterinarian setting; or

  1. animal carcasses:

(i) in a farming setting; or

(ii) in a veterinarian setting; or

  1. human corpses:

(i) in a healthcare services setting; or

(ii) in a mortuary setting; or

  1. persons (individuals) in a healthcare services setting.

10

Malaria

Employment involving work in a region where malaria is endemic.

Malignant diseases

11

Primary malignant disease of the salivary gland

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

12

Primary malignant disease of the nasopharynx

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. formaldehyde; or
  2. wood.

13

Primary malignant disease of the oesophagus

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

14

Primary malignant disease of the stomach

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

15

Primary malignant disease of the colon or rectum

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

16

Primary malignant disease of the liver

Employment for at least 5 years (whether consecutive or not) involving work with vinyl chloride monomer.

17

Primary malignant disease of the nasal cavity or para-nasal sinuses

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation; or
  3. nickel; or
  4. leather; or
  5. wood.

18

Primary malignant disease of the larynx

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. asbestos; or
  2. asbestos-containing material; or
  3. acid mist (strong inorganic).

19

Primary malignant disease of the lung caused by asbestos

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. asbestos; or
  2. asbestos-containing material.

20

Primary malignant disease of the bone

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

21

Primary malignant disease of the mesothelium

Employment for at least three months (whether consecutive or not) involving work with:

  1. asbestos; or
  2. asbestos-containing material.

22

Primary malignant disease of the breast

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

23

Primary malignant disease of the ovary

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. asbestos; or
  2. asbestos-containing material.

24

Primary malignant disease of the kidney

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation; or
  3. trichloroethylene.

25

Primary malignant disease of urothelial tissue lining the urinary tract

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation; or
  3. 2-naphthylamine; or
  4. benzidine; or
  5. cyclophosphamide; or
  6. ortho-toluidine; or
  7. polycyclic aromatic hydrocarbons during aluminium production.

26

Primary malignant disease of the brain

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

27

Primary malignant disease of the thyroid

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation.

28

Primary leukaemia (excluding chronic lymphatic leukaemia)

Employment for at least 2 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation; or
  3. benzene; or
  4. butadiene; or
  5. cyclophosphamide; or
  6. formaldehyde.

29

Primary non-Hodgkins lymphoma

Employment for at least 2 years (whether consecutive or not) involving work with:

  1. equipment that produces ionising radiation; or
  2. substances that emit ionising radiation; or
  3. pentachlorophenol; or
  4. lindane.

30

Cholangiocarcinoma

Employment for at least 5 years (whether consecutive or not) involving work with 1,2 Dichloropropane.

31

Ocular melanoma

Employment for at least 5 years (whether consecutive or not) involving work with welding (producing ultraviolet light).

Diseases of the nervous system

32

Parkinson’s disease

Employment for at least one year (whether consecutive or not) involving work with manganese.

33

Peripheral neuropathy

Employment for at least one year (whether consecutive or not) involving work with:

  1. acrylamide; or
  2. arsenic; or
  3. carbon disulphide; or
  4. lead; or
  5. mercury; or
  6. n-hexane; or
  7. organophosphates; or
  8. trichloroethylene.

Respiratory diseases

34

Occupational asthma

Employment for at least 4 weeks (whether consecutive or not) involving work with an agent or thing specified in column 2 of an item of the table in Schedule 2.

35

Coal workers’ pneumoconiosis

Employment for at least 5 years (whether consecutive or not) involving work with coal.

36

Asbestosis

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. asbestos; or
  2. asbestos-containing material.

37

Silicosis

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. material containing crystalline silica; or
  2. silica.

38

Other pneumoconiosis

Employment for at least 5 years (whether consecutive or not) involving work with:

  1. aluminium; or
  2. barium; or
  3. beryllium; or
  4. cobalt; or
  5. iron oxide; or
  6. tin; or
  7. tungsten.

39

Byssinosis

Employment for at least 4 weeks (whether consecutive or not) involving work with:

  1. unprocessed cotton; or
  2. unprocessed flax; or
  3. unprocessed hemp; or
  4. unprocessed sisal.

40

Extrinsic allergic alveolitis

Employment for at least 4 weeks (whether consecutive or not) involving work with:

  1. feathers; or
  2. grain; or
  3. hay; or
  4. straw.

Hepatic disease

41

Non-infectious hepatitis

Employment involving work with:

  1. acrylonitrile; or
  2. alcohols; or
  3. amino-derivatives of benzene; or
  4. antimony; or
  5. aromatic hydrocarbons; or
  6. arsenic; or
  7. benzene; or
  8. benzoquinone; or
  9. beryllium; or
  10. cadmium; or
  11. carbon disulphide; or
  12. carbon monoxide; or
  13. chromium; or
  14. copper; or
  15. fluorine; or
  16. glycols; or
  17. hexane; or
  18. hydrogen cyanide; or
  19. hydrogen sulphide; or
  20. ketones; or
  21. lead; or
  22. manganese; or
  23. mercury; or
  24. methylene chloride; or
  25. mineral acids; or
  26. nitric acid esters; or

(za) organochlorine compounds; or

(zb) organophosphate; or

(zc) osmium; or

(zd) oxides of nitrogen; or

(ze) ozone; or

(zf) phosgene; or

(zg) phosphorus; or

(zh) selenium; or

(zi) styrene; or

(zj) thallium; or

(zk) tin; or

(zl) toluene; or

(zm) toxic halogen derivatives of aliphatic; or

(zn) toxic nitro-derivatives of benzene; or

(zo) vanadium; or

(zp) zinc.

Skin diseases

42

Irritant contact dermatitis

Employment for at least 4 weeks (whether consecutive or not) involving work and contact with:

  1. alcohols; or
  2. cutting fluids; or
  3. cleaners; or
  4. degreasers; or
  5. disinfectants; or
  6. liquids (frequent contact); or
  7. liquids (prolonged contact); or
  8. petroleum products; or
  9. soaps; or
  10. solvents.

43

Allergic contact dermatitis

Employment for at least 4 weeks (whether consecutive or not) involving work and contact with:

  1. 2,5-diaminotoluene sulfate; or
  2. 4-phenylenediamine base; or
  3. ammonium persulfate; or
  4. cobalt chloride; or
  5. cocamide diethanolamide; or
  6. coconut diethanolamide; or
  7. colophonium/colophony/rosin; or
  8. diazolidinyl urea; or
  9. epoxy resin; or
  10. formaldehyde; or
  11. fragrance mix I:

(i) amylcinnamaldehyde; or

(ii) cinnamic alcohol; or

(iii) cinnamic aldehyde;

(iv) eugenol; or

(v) geraniol; or

(vi) hydroxycitronellal; or

(vii) isoeugenol; or

(viii) oakmoss absolute; or

  1. fragrance mix II:

(i) citral; or

(ii) citronellol; or

(iii) coumarin; or

(iv) farnesol; or

(v) hexyl cinnamic aldehyde; or

(vi) hydroxyisohexyl 3-cyclohexene carboxaldehyde; or

  1. glyceryl monothioglycolate; or
  2. hydroxyethyl methacrylate; or
  3. mercaptobenzothiazole; or
  4. methyl chloroisothiazolinone; or
  5. mixture of methylchloroisothiazolinone and methylisothiazolinone; or
  6. nickel sulfate; or
  7. potassium dichromate; or
  8. quaternium 15; or
  9. thiuram mix:

(i) tetramethylthiuramdisulfide; or

(ii) tetramethylthiuram monosulfide; or

(iii) tetraethylthiuram disulfide.

44

Occupational vitiligo

Employment for at least 4 weeks (whether consecutive or not) involving work with:

  1. hydroquinone; or
  2. monobenzyl ether of hydroquinone; or
  3. monobutyl ether of hydroquinone; or
  4. para-amylphenol; or
  5. para-tertiary-butylcatechol; or
  6. para-tertiary-butylphenol.

Musculoskeletal diseases

45

Raynaud’s disease

Employment for at least 12 weeks (whether consecutive or not) involving work with:

  1. powered equipment that produces vibration; or
  2. powered tools that produce vibration.

46

Bursitis at the elbow or knee

Employment for at least 6 months (whether consecutive or not) involving a work activity that:

  1. for bursitis at the elbow:

(i) involves prolonged external friction at or about the elbow; or

(ii) involves prolonged external pressure at or about the elbow; or

(iii) involves recurrent external friction at or about the elbow; or

(iv) involves recurrent external pressure at or about the elbow; or

  1. for bursitis at the knee:

(i) involves prolonged external friction at or about the knee; or

(ii) involves prolonged external pressure at or about the knee; or

(iii) involves recurrent external friction at or about the knee; or

(iv) involves recurrent external pressure at or about the knee.

Acute diseases

47

Acute poisoning or toxicity affecting the heart, lungs, liver, kidney, nervous system or blood

The same as for item 38.

\n```\n\n \n\nSchedule 2—Occupational asthma\n\n| | Column 1 | Column 2 |\n| ---- | -------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Item | Class of agent or thing | Specified agent or thing |\n| 1 | Arthropods | acarian; orbarn mite; orcaddisfly; orcricket; orEphestia kuehniella (Mediterranean flour moth); orfowl mite; orfruit fly; orgrain mite; orflour mite; orlesser mealworm; orlocust; orsheep blowfly; orsilkworm. |\n| 2 | Acids | dodecanedioic acid; orglacial acetic acid; orhydrochloric acid; orperoxyacetic acid; orsulphuric acid; orsulphur dioxide. |\n| 3 | Acrylates | acrylic acid; orcyanoacrylates; ormethyl methacrylate; orpolymethyl methacrylate; ortrimethylolpropane triacrylate/2-hydroxypropyl acrylate. |\n| 4 | Aldehydes | formaldehyde; orgluteraldehyde; orparaformaldehyde; orurea formaldehyde. |\n| 5 | Amines | aminoethyl ethanolamine; ordiethanolamine; ordimethylethanolamine; orethanolamines; orethylenediamine; ormonoethanolamine; orsurfactant-specific amines; ortriethanolamine; ortriethylenetetramine; ortrimethylhexane-1; or6-diamine/isophorondiamine mixture. |\n| 6 | Ammonias | anhydrous ammonia; orammonium hydroxide; orammonia solution 10%; orammonia solution 29%. |\n| 7 | Anhydrides | hexahydrophthalic anhydride; orhimic anhydride; ormaleic anhydride; ormethyl tetrahydrophthalic; oranhydride; orphthalic anhydride; ortetrachlorophthalic anhydride; ortrimellitic anhydride. |\n| 8 | Bio-aerosols | Alternaria; orChrysonilia sitophilia; orNeurospora; orPenicillium; orcutting oils. |\n| 9 | Biological enzymes | Bacillus subtilis enzymes; orbromelain; oregg lysozyme; oresperase; orflaviastase; orfungal amylase; orfungal amyloglucosidase; orfungal hemicellulose; orpancreatin; orpapain; orpepsin; ortrypsin. |\n| 10 | Epoxy | epoxy; orepoxy adhesive. |\n| 11 | Ethylene oxide | ethylene oxide. |\n| 12 | Flours | buckwheat flour; orrye flour; orsoya flour; orwheat flour. |\n| 13 | Flowers | baby’s breath; orfreesia; orLimonium tataricum; orsunflower. |\n| 14 | Foods | Brazil ginseng; orcastor bean; orchamomile; orcinnamon; orDioscorea batatas (Chinese yam); oregg protein; orfenugreek; orgarlic dust; orgreen beans; orguar; orhops; orpaprika; orpectin; orrose hips; orsoybean lecithin; ortea; orthiamine (vitamin B); orthyme. |\n| 15 | Industrial cleaning and sterilising agents | alkyl dimethyl benzyl ammonium chloride; orbenzyl-C10-16-alkyldimethyl, chlorides; orbenzyl-C12-16-alkyldimethyl, chlorides; orbenzyl-C12-18-alkyldimethyl, chlorides; orbenzyl-C16-18-alkyldimethyl, chlorides; orbenzyldimethylstearyl ammonium chloride; orcetalkonium chloride; orchlorhexidine; orchlorine; ordialkyl methyl benzyl ammonium chloride; ordicumyl-peroxide; ordodecyl dimethyl ammonium chloride; ordimethyl ethyl benzyl ammonium chloride; ordodecyl-dimethylbenzylammonium; orfluorine; orn-alkyl dimethyl benzyl ammonium chloride; orpersulphate salts; orsodium hypochlorite; orsodium metabisulfite. |\n| 16 | Isocyanates | diisocyanates; orhexamethylene diisocyanate prepolymers; orisocyanates; ortoluene diisocyanate prepolymers. |\n| 17 | Latex | latex; ornatural rubber. |\n| 18 | Medications | ampicillin; oramprolium; orcimetidine; orcodeine; orcolistin; orhydralazine; oripecacuanha; orhydrocodone; orisonicotinic acid hydrazide; ormethyldopa; ormorphine; oropiate compounds; oroxycodone; orpapaverine; orpenicillamine; orpenicillins; orphenylglycine acid chloride; orpsyllium; orsalbutamol intermediate; orspiramycin; ortetracycline; orthebaine; ortylosin tartrate; orvancomycin. |\n| 19 | Metals | aluminium; oraluminium chloride; oraluminium oxide; oraluminium compounds; orammonium dichromate; orammonium hexachloroplatinate (IV); orchromium; orchromium, metal; orchromium, hexavalent; orchromium, non-hexavalent; orcobalt; orcobalt compounds; ornickel; ornickel compounds; orplatinum; orrhodium; orsoluble halogenated platinum compounds; ortitanium oxide/dioxide; ortributyl tin oxide; ortungsten carbide; ortungsten carbide/cobalt; orvanadium; orwelding fumes – gas metal arc welding on uncoated mild steel; orwelding fumes – stainless steel; orstainless steel; orzinc oxide. |\n| 20 | Other reactive chemicals | chlorofluorocarbon refrigerants heated; orfluoride; orfurfuryl alcohol mixed with a catalyst; orisolyzer; orpolyethylene terephthalate/polybutylene terephthal; orpolyfunctional aziridine; orpolypropylene heated; orpolyvinyl chloride heated; orpolyvinyl chloride non-heated; orpolyvinyl chloride thermally degraded; orradiographic fixative; orresin containing furfuryl alcohol; orstyrene; ortrigylicidyl isocyanurate. |\n| 21 | Pesticides | 3-amino-5-mercapto-1;2;4-triazole; oracephate; orchloramine T; orchlorothalonil (bravo, echo); ordiazinon; ordimethoate; orfenthion; ormalathion; ornemacur; orpiperazine; orpiperazine citrate; orpiperazine hydrochloride; orpyrethrins; orpyrfon; orsafrotin; ortetramethrin. |\n| 22 | Plants and sensitising agents or irritants derived from plants | almond dust; orArabidopsis thaliana; orChlorella algae; orgum arabic; orhenna; orkapok; orlinseed oilcake; orPinellia ternata; orquillaja bark; orrice dust; ortall oil crude; ortall oil – rosin; ortobacco leaf; ortragacanth; orturpentine; orVicia sativa (vetch); orweeping fig. |\n| 23 | Reactive dyes | Cibachrome Brilliant Scarlet 32; orDrimarene Brilliant Blue K-BL; orDrimarene Brilliant Yellow K-3GL; orLanasol Yellow 4G; orLevafix Brilliant Yellow E36; orMethyl Blue; orRifacion Orange HE 2G; orRifafix Yellow 3 RN; orRifazol Black GR; orRifazol Brilliant Orange 3R. |\n| 24 | Sensitising agents or irritants derived from animals | bat guano; orbovine serum albumin; orcasein; orcat antigens; orchicken antigens; orcow antigens; orfrog antigens; orguinea pig antigens; orlactoserum; ormice antigens; orpig antigens; orrabbit antigens; orrat antigens. |\n| 25 | Sensitising agents or irritants derived from fish or shellfish | Anisakis simplex (herring worm) antigens; orclam antigens; orcrab antigens; orcuttlefish antigens; orfishmeal; ornacre dust; oroctopus antigens; orprawn antigens; orred soft coral antigens; orsalmon antigens; orshrimp meal; ortrout antigens. |\n| 26 | Soldering fluxes | colophony soldering flux; oralkyl aryl polyether soldering flux; orzinc soldering flux. |\n| 27 | Wood | Triplochiton scleroxylon (African maple); orAcacia melanoxylon (blackwood); orSequoia sempervirens (California redwood); orJuglans olanchana (Central American walnut); orThuja occidentalis (eastern white cedar); orShoreal sp. (mahogany); orQuercus robur (oak); orThuja lpicata (western red cedar). |\n| | | |\n\nSchedule 3—Repeals\n\nNote: See section 6\n\n Seafarers Rehabilitation and Compensation Act 1992 – Notice of Declarations and Specifications (25/05/1993)\n\n1 The whole of the instrument\n\nRepeal the instrument.","sortOrder":7}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":1897},"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"This instrument replaces the 1993 specification notice but maintains the same fundamental scope: establishing a deemed connection between specified diseases and employment for seafarers' compensation purposes. While the specific medical conditions and exposure agents have been updated to reflect current occupational health knowledge, the legislative purpose and coverage remain consistent with the original 1993 instrument."},"complexity_factors":["Extensive technical medical and chemical nomenclature (ionising radiation, vinyl chloride monomer, organophosphates, etc.)","Multiple cross-references between Schedule 1 and Schedule 2 for occupational asthma agents","Variable time-based qualifying periods (ranging from 4 weeks to 5 years, with 'whether consecutive or not' conditions)","Nested sub-lists specifying particular exposure scenarios (e.g., specific animals, specific healthcare settings)","Classification of diseases into 8 distinct medical categories (infectious, malignant, nervous system, respiratory, hepatic, skin, musculoskeletal, acute)"],"plain_english_summary":"This instrument creates a “deemed list” of 47 occupational diseases for seafarers so that if a listed disease occurs after specified work exposure the condition is automatically presumed work‑related, removing the need for the worker to prove causation. It links diseases to particular activities/exposures, sets minimum exposure periods for many claims, includes detailed chemical/agent lists for asthma triggers, replaces the 1993 list, and expires automatically after five years."},"flash_summary":{"complexity_score":8,"scope_assessment":{"changed":true,"description":"Yes. The instrument replaces earlier specifications by expressly repealing the 1993 instrument (Schedule 3) and re‑specifying which diseases are related to seafaring employment under paragraph 10(1)(b) of the Act (s3, s7). It updates and consolidates disease-to-employment links (including a new, detailed occupational asthma table in Schedule 2), sets the temporal application to diseases suffered on or after commencement (s5), and imposes a five-year automatic repeal (s8)."},"complexity_factors":["Detailed, extensive schedules listing many diseases each tied to specific exposures or work activities (Schedule 1) — increases factual and evidential complexity for claims.","Varied exposure-duration thresholds across items (eg. 'at least 5 years', 'at least 3 months', 'at least 4 weeks') requiring proof of employment history (see multiple items in Schedule 1).","Large, technical lists of substances and agents (chemicals, metals, biological agents) that require expert interpretation (see Schedule 1 and Schedule 2).","Separate, comprehensive table for occupational asthma naming many classes and specific agents (Schedule 2) and cross-reference from Schedule 1, item 34 — creates cross-document dependence.","Legal cross-references to the parent Act authority (paragraph 10(1)(b) of the Act; see s3 and s7) mean determinations sit within statutory scheme rather than free-standing rules.","Sunset clause and repeal mechanics: the instrument self-repeals after five years (s8) and expressly repeals an earlier 1993 instrument (Schedule 3) — complicates transitional and historical comparisons.","Simple definitions section that limits interpretation (eg. 'disease' ordinary meaning; 'substance' defined) but leaves clinical causation and exposure measurement to administrative/medical processes (s4, s7).","Administrative burden for claimants and decision-makers to assemble employment, exposure and medical evidence needed to match facts to specific schedule items (implied by the exposure/time criteria throughout Schedule 1)."],"plain_english_summary":"This instrument specifies which diseases are treated as work-related under the Seafarers Rehabilitation and Compensation Act 1992 by naming diseases and the kinds of employment or exposures that link them to seafaring work. It sets exposure-duration thresholds and detailed lists of substances and agents (including a separate table for occupational asthma), applies to diseases suffered on or after commencement, and automatically expires after five years. It primarily affects employees making compensation claims and the officials who determine entitlement under the Act."}},"importantCases":[],"_links":{"self":"/api/acts/seafarers-rehabilitation-and-compensation-specified-diseases-and-employment-instrument-2021","history":"/api/acts/seafarers-rehabilitation-and-compensation-specified-diseases-and-employment-instrument-2021/history","analysis":"/api/acts/seafarers-rehabilitation-and-compensation-specified-diseases-and-employment-instrument-2021/analysis","conflicts":"/api/acts/seafarers-rehabilitation-and-compensation-specified-diseases-and-employment-instrument-2021/conflicts","importantCases":"/api/acts/seafarers-rehabilitation-and-compensation-specified-diseases-and-employment-instrument-2021/important-cases","documents":"/api/acts/seafarers-rehabilitation-and-compensation-specified-diseases-and-employment-instrument-2021/documents"}}